ROSH-HA`AYIN, Israel, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market...
BEIJING, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the...
MONETT, Mo., Aug. 7, 2024 /PRNewswire/ -- Jack Henry & Associates, Inc.® (NASDAQ: JKHY) announced today that it will host...
SHENZHEN, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading...
- Multiple clinical milestones across portfolio anticipated in second half of 2024, including two Phase 2 trials assessing belrestotug +...
Iteris detection and connected vehicle technology will work together to improve safety at high-impact intersections Contacts Media Contact Breanna Wallace...
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
– LINZESS® (linaclotide) EUTRx prescription demand growth of 11% year-over-year – – Plans to pursue apraglutide rolling NDA review; expects...
Reached an important agreement with a major platform partner to supply a bundle of InnovizTwo short- and long-range LiDARs to...
BELO HORIZONTE, Brazil, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading financial super...
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $90.3 Million for the Second Quarter of 2024, Reflecting 17% Growth Over...
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B...
Company to Host Conference Call Today at 9 a.m. ETMIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- International Money Express, Inc....
– Jason Tardio, Experienced Multiple Sclerosis Drug Commercialization Executive, Formerly with Novartis and Biogen, Appointed Chief Operating Officer and President...
SYDNEY, AUSTRALIA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology...
BOSTON and ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical...
SHANGHAI, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“Intchains” or the “Company”), a provider of...
CAESAREA, Israel, Aug. 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive...
NEW YORK and TOKYO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a...
– Positive data from ongoing Phase 1/1b clinical trial of WTX-124 presented at American Society of Clinical Oncology (ASCO) Annual Meeting...
The Company Also Announces the Opening of a New Canna Cabana Store in Belleville, Ontario CALGARY, AB, Aug. 8, 2024...
Q2 2024 Revenues Surpassed Guidance while Gross Margin and EPS In Line With Guidance Range Issued on May 9, 2024Company...
- Entered into Definitive Merger Agreement to be Acquired by Pharmacosmos; Transaction Expected to Close in Late Third Quarter 2024...
SAN MATEO, Calif., Aug. 8, 2024 /PRNewswire/ -- GoPro, Inc. (NASDAQ: GPRO) today announced that Founder and Chief Executive Officer Nicholas...
CHICAGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace...
IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate...
Revenue Increased by 13% Year-over-Year,GAAP Operating Income of $2.8 Million andAdjusted EBITDA of $10.1 MillionRead more at globenewswire.com
U.S. commercial launch of RYTELO™ (imetelstat) began in June 2024 for patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia...
Contacts Investor Contact GoodRx Aubrey Reynolds ir@goodrx.com Press Contact GoodRx Lauren Casparis lcasparis@goodrx.com GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us,"...
AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software...
Q2 2024 Total Revenue of $126.7M, a 34% Increase Year-over-YearGalafold® Q2 Revenue of $110.8M, up 17% Year-over-YearRead more at globenewswire.com
Topline Phase 1 dose escalation data for FHD-286 in combination with decitabine, in relapsed and/or refractory AML patients, anticipated in...
Second Quarter 2024 Highlights1Reaffirming Standalone First Advantage Full-Year 2024 GuidanceRead more at globenewswire.com
WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and...
Contacts Investor: investor.relations@nationalvision.com National Vision Holdings, Inc. Tamara Gonzalez ICR, Inc. Caitlin Churchill Media: media@nationalvision.com National Vision Holdings, Inc. Racheal...
Anfield deploys Wi-Fi to help drive more engaging digital fan experiences and streamline stadium operations Contacts Media Blair Donald (603)...
Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress...
SAN FRANCISCO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
HAIFA, Israel, Aug. 8, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced...
